Last reviewed · How we verify
NCT05482633
Inspiratory Muscle Training in Juvenile Idiopathic Arthritis
NA trial testing Inspiratory muscle training (IMT) in Juvenile Idiopathic Arthritis in 33 participants. Completed in 15 September 2022.
15 September 2022
Quick facts
| Lead sponsor | Izmir Katip Celebi University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 33 |
| Start date | 1 July 2022 |
| Primary completion | 15 September 2022 |
| Estimated completion | 15 September 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Inspiratory muscle training (IMT)
Conditions studied
- Juvenile Idiopathic Arthritis — all drugs for Juvenile Idiopathic Arthritis →
Sponsor
Izmir Katip Celebi University
Who can join
Adults 13 to 18, any sex, with Juvenile Idiopathic Arthritis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to investigate the effectiveness of inspiratory muscle training (IMT) in increasing respiratory muscle strength in patients with juvenile idiopathic arthritis.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05482633
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Inspiratory muscle training (IMT)
Trials testing the same drug.
- NCT06087900 — Effect of Different Exercise Modalities Training in Patients With Obstructive Sleep Apnea. · NA · completed
- NCT05024474 — Effects of Inspiratory Muscle Training After Covid-19 (ReCOV) · NA · completed
- NCT04686019 — More Air - Better Performance - Faster Recovery · NA · unknown
- NCT03911206 — A Trial Assessing the Safety and Feasibility of Respiratory Muscle Training and Exercise Training in Children and Adoles · NA · completed
Other recruiting trials for Juvenile Idiopathic Arthritis
Currently open trials in the same condition.
- NCT07243782 — Regulatory Post-Marketing Surveillance in Hidradenitis Suppurativa, Pediatric Plaque Psoriasis and JIA Treated With Cose · recruiting
- NCT05879419 — Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases · Phase 4 · active not recruiting
- NCT06007456 — Clinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic Arthritis · recruiting
- NCT03913962 — Health and Exercise Response in Children With Chronic and Auto-immune Pathologies · NA · recruiting
- NCT06560606 — UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease · recruiting
Other Izmir Katip Celebi University trials
Trials by the same sponsor.
- NCT07460479 — Pilot Study of an Extended CBT Group Intervention for Intolerance of Uncertainty · NA · recruiting
- NCT07453277 — Blood-Based Molecular Clock Biomarkers Predict Acute Ischemic Stroke Onset: A Prospective Observational Study · active not recruiting
- NCT07341646 — Effect of Cuff Pressure Assessment Methods on Postoperative Complications in Breast Surgery · NA · not yet recruiting
- NCT07304661 — Comparison of PPV and LVOT VTI During Passive Leg Raising to Predict Fluid Responsiveness · not yet recruiting
- NCT07304648 — Role of End-Tidal CO2 During Passive Leg Raising to Predict Fluid Responsiveness in ICU · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05482633 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Izmir Katip Celebi University
- Last refreshed: 28 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05482633.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing